Provider record
Fifty 410: What We Hold, and What We Have Asked
We hold 1 price record for Fifty 410, the lowest at $133 a month. At least one is a capture we made ourselves. Fifty 410 has answered none of the four disclosure…
We hold 1 price record for Fifty 410, the lowest at $133 a month. At least one is a capture we made ourselves. Fifty 410 has answered none of the four disclosure questions we publish, so most of the fields that decide a recommendation are blank on this page.
Why is this a record rather than a review?
Our provider reviews run to about 2,500 words because we hold enough on those companies to write that much without padding. For Fifty 410 we do not. Writing the same length from one uncaptured figure would produce something that reads authoritative and tells you nothing.
So this page publishes exactly what we hold, marks every gap, and states what we have asked for. It becomes a review when there is something to review.
Every record we hold
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| Fifty 410 | pay per programme | compounded injectable | Starting programme | $133 | $0 | $133 | Recurring | Verified | 2026-07-27 |
What we have asked, and what is unanswered
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | — | Not answered No public price |
| Clinical oversight and care continuity | 20 pts | — | Not answered No public price |
| State access and operational reliability | 10 pts | — | Not answered No public price |
| Cancellation, billing and support transparency | 10 pts | — | Not answered No public price |
A dash means no figure held. How we grade evidence.
What is missing from the record, and why does that matter?
The blank cells above are not omissions. Until Fifty 410 names its fulfilling pharmacy and registration class, a reader cannot check that pharmacy against a state board or against FDA warning letters, and cannot tell whether the FDA's proposed 503B bulks exclusion affects their supply. Until it publishes an all-in price at a maintenance dose, the figure above describes the start of treatment rather than the cost of it.
Both are things Fifty 410 can change in an afternoon, and we publish the answer either way — see the disclosure register.
Frequently asked questions
Is Fifty 410 legitimate?
We have not assessed that. We hold price records and no answers to our disclosure questions, which is not enough to make a judgement in either direction.
How much does Fifty 410 cost?
The lowest figure we hold is $133 a month, and it is captured by us. We do not know what it becomes at a maintenance dose.
Which pharmacy does Fifty 410 use?
They have not told us. No provider in our dataset has answered that question.
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Ro Body Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- How to Get Tirzepatide Online SafelyPillar / Money
- Henry Meds Tirzepatide ReviewProviders
- GLP-1 and Tirzepatide NewsNews
Related coverage
- Enhance.MD Tirzepatide Review
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- FDA Proposes Permanent Exclusion of Semaglutide, Tirzepatide and Liraglutide From the 503B Bulks List
- Comment Period on the GLP-1 Bulks Proposal Extended to 30 July
- FDA Signals It Will Restrict GLP-1 Active Ingredients Used in Non-Approved Compounded Products
- FDA Panel Recommends Six of Seven Peptides for Compounding, Overriding Its Own Scientists
- FDA Advisory Committee Reviews BPC-157, TB-500 and Five Other Peptides This Week
- Foundayo is $149 self-pay, and the Complete Response Letter claim is false
Semaglutide Ranked. “Fifty 410: What We Hold, and What We Have Asked.” S.J Partners LLC, 2026-07-26. https://semaglutideranked.com/providers/fifty-410/
Quote the capture date beside a figure, not the date you read this page. Why.